(Reuters) – Teva Pharmaceutical Industries Ltd. said on Sunday that it had agreed to pay a $ 85 million deal with the states of Oklahoma before the company was facing charges of allegations that it and other drugs helped burn the US opioid epidemic.
Teva, the world's largest generic drug company, said the settlement "did not fix any errors in the company" and denied contributing to opioid abuse in Oklahoma.
Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers produced.
The trial against Israel-based Teva, along with Johnson & Johnson, would begin on Tuesday. The lawsuit felt that the companies' marketing of painkillers was to blame the opioid epidemic.
In a statement, Janssen Pharmaceuticals Inc., a J&J subsidiary, said it had acted responsibly and was ready for trial. It considered that it disagreed with what it called Oklaw's "too expansive theories" of anti-social laws and said they should not apply in this situation.
"While with all disputes, if an appropriate resolution is possible to avoid the cost and uncertainty of a trial, we are always open to that option, the company said in a statement.
Oklahoma lawyer Mike Hunter has claimed that J & J and Teva together with OxyContin manufacturer Purdue Pharma LP conducted fraudulent labeling campaigns that played down the addictive risks of opioids and exaggerated their benefits. $ 7 billion to $ 1
Oklahoma solved its claims against Purdue Pharma LP in March for $ 270 million.
The Oklahoma case is closely monitored by the plaintiff in other opioid cases, especially about 1,850 mostly municipal and state governments that have sued the same drug company in the federal court in Ohio. 9659002] "Teva is happy to add the Oklahoma case behind it and is still prepared to vigorously defend claims against the company, including the upcoming court in Cleveland where the majority of cases are waiting," the company said.
The Attorney General Hunter Office said in a statement that the money would be used to deal with the opioid crisis in Oklahoma and that the J&J case is still scheduled to go to trial on Tuesday prior to the Cleveland County District Thad Balkman.
"Almost all Oklahoma men have been negatively affected by this deadly crisis and we look forward to Tuesday, where we will prove our case against Johnson & Johnson and its subsidiaries," said Mr Hunter. in a statement.